text.skipToContent text.skipToNavigation
AliveDx_brand_logo.png

ALIVEDX

AliveDX develops and commercialises advanced diagnostic solutions across autoimmunity and infectious diseases. Its portfolio includes multiplex immunoassays and automated platforms designed to deliver high sensitivity, specificity, and laboratory efficiency. AliveDX technologies support clinical laboratories in improving turnaround times, reducing manual workflows, and enhancing diagnostic confidence. With a focus on innovation and scalable solutions, AliveDX addresses the growing demand for precision diagnostics in complex disease areas.

About AliveDx

AliveDx is a global diagnostics company with over 30 years of expertise in in-vitro diagnostics, focused on advancing specialty testing across autoimmunity, allergy, and transfusion diagnostics. By designing easy-to-use, high-performance systems, AliveDx enables laboratories to shorten diagnostic turnaround times and support earlier, more informed clinical decision-making.

At the forefront of its portfolio is MosaiQ®, one of the first multiplexing and multimodality automated testing platforms, transforming how complex conditions are detected and managed. By enabling simultaneous analysis of multiple biomarkers, MosaiQ® delivers fast, actionable insights while simplifying traditionally labour-intensive workflows.

MosaiQ 125 Instrument – AutoImmune and Allergy Testing
Features: Benefits:
  • High-throughput capability
  • Fully automated workflow
  • Multiplex microarray technology
  • Scalable testing for growing laboratory demand
  • Reduced hands-on time and minimised manual error
  • Simultaneous detection of multiple biomarkers, improving diagnostic efficiency

Complementing this, LumiQ® enhances indirect immunofluorescence (IFA) — the gold standard for autoantibody testing — through automation and workflow optimisation. Together, MosaiQ® and LumiQ® provide a comprehensive, integrated solution for autoimmune diagnostics, supporting both high-throughput screening and confirmatory testing.

LumiQ Automated IFA Instrument
Features: Benefits:
  • Automated IFA (sample-to-result)
  • Dual-batch processing capability
  • Standardised processing and interpretation
  • Reduced manual handling and improved consistency
  • Increased throughput without additional resources
  • Improved reproducibility and reduced variability
Partner with DKSH New Zealand

At DKSH New Zealand, our specialist Clinical Diagnostics team supports the distribution, implementation, and market expansion of AliveDx technologies across Australia and New Zealand. With deep expertise in healthcare logistics, regulatory support, technical and operational service, DKSH enables laboratories to access and adopt innovative diagnostic solutions with confidence.

Through our extensive distribution network, local application specialists, and in-market regulatory expertise, DKSH ensures that AliveDx solutions are:

  • Delivered efficiently
  • Supported locally
  • Seamlessly integrated into laboratory workflows

Engage with DKSH New Zealand's Clinical Diagnostics specialists to explore how AliveDx solutions can be implemented within your laboratory.
We provide:

  • Product demonstrations and application support
  • Workflow optimisation guidance
  • Market-leading diagnostic technologies aligned with clinical demand

Discover how AliveDx and DKSH New Zealand can support Auto Immunity and Allergy Testing.

sideresourcesimedia

Get easy access to key resources and brochures

Explore Now